Targeting B cell receptor signalling in cancer: preclinical and clinical advances

JA Burger, A Wiestner - Nature Reviews Cancer, 2018 - nature.com
B cell receptor (BCR) signalling is crucial for normal B cell development and adaptive
immunity. BCR signalling also supports the survival and growth of malignant B cells in …

Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo-and immunotherapies

G Genard, S Lucas, C Michiels - Frontiers in immunology, 2017 - frontiersin.org
Tumor-associated macrophages (TAMs) play a central role in tumor progression, metastasis,
and recurrence after treatment. Macrophage plasticity and diversity allow their classification …

Nanomedicines for the treatment of hematological malignancies

AK Deshantri, AV Moreira, V Ecker… - Journal of Controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …

CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

DK Edwards, K Watanabe-Smith… - Blood, The Journal …, 2019 - ashpublications.org
To identify new therapeutic targets in acute myeloid leukemia (AML), we performed small-
molecule and small-interfering RNA (siRNA) screens of primary AML patient samples. In …

Targeting the tumor microenvironment of leukemia and lymphoma

UE Höpken, A Rehm - Trends in cancer, 2019 - cell.com
Despite progress in exploiting therapeutically the genetic vulnerabilities of leukemia and
lymphoma, the outcome is often extended progression-free survival but not tumor …

Macrophage-and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo

C Martines, S Chakraborty, M Vujovikj… - Blood, The Journal …, 2022 - ashpublications.org
A large amount of circumstantial evidence has accumulated suggesting that Toll-like
receptor (TLR) signals are involved in driving chronic lymphocytic leukemia (CLL) cell …

The role of tumor-associated macrophages in hematologic malignancies

E Cencini, A Fabbri, A Sicuranza, A Gozzetti… - Cancers, 2021 - mdpi.com
Simple Summary Tumor-associated macrophages (TAM) represent a leading component of
the tumor microenvironment in hematologic malignancies. TAM could display antitumor …

Hematopoietic stem cell niche during homeostasis, malignancy, and bone marrow transplantation

Y Man, X Yao, T Yang, Y Wang - Frontiers in Cell and Developmental …, 2021 - frontiersin.org
Self-renewal and multidirectional differentiation of hematopoietic stem cells (HSCs) are
strictly regulated by numerous cellular components and cytokines in the bone marrow (BM) …

The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

JG Valero, A Matas-Céspedes, F Arenas, V Rodriguez… - Leukemia, 2021 - nature.com
Microenvironment contributes to follicular lymphoma (FL) pathogenesis and impacts survival
with macrophages playing a controversial role. In the present study, using FL primary …

Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid-and lymphoid-derived hematologic malignancies

SE Kurtz, CA Eide, A Kaempf… - Proceedings of the …, 2017 - National Acad Sciences
Translating the genetic and epigenetic heterogeneity underlying human cancers into
therapeutic strategies is an ongoing challenge. Large-scale sequencing efforts have …